ASP7266, a Novel Antibody Against Human TSLPR, in the Treatment of Allergic Disease

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2017.12.042
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Novel Microbe-Based Treatment That Attenuates the Inflammatory Profile in a Mouse Model of Allergic Airway Disease

Scientific Reports
Multidisciplinary
2016English

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas

Frontiers in Immunology
AllergyImmunology
2018English

A Novel Bispecific Antibody Against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy

PLoS ONE
Multidisciplinary
2015English

A Novel Intracellular Antibody Against the E6 Oncoprotein Impairs Growth of Human Papillomavirus 16-Positive Tumor Cells in Mouse Models

Oncotarget
Oncology
2016English

A Novel Antibody Against Human Properdin Inhibits the Alternative Complement System and Specifically Detects Properdin From Blood Samples

PLoS ONE
Multidisciplinary
2014English

Novel Antibody Switching Defects in Human Patients

Journal of Clinical Investigation
Medicine
2003English

Novel Human Antibody Therapeutics: The Age of the Umabs

Biotechnology Journal
Applied MicrobiologyBiotechnologyMolecular MedicineMedicine
2008English

Assessment of Tumor Growth Factor‑β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Antibody Against Influenza A2 Virus Neuraminidase in Human Sera

Journal of Hygiene
1969English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy